DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Decadron (Dexamethasone) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (20)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Decadron (Dexamethasone) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Decadron side effects in male

Reported by a physician from United States on 2012-08-17

Patient: male, weighing 88.4 kg (194.6 pounds)

Reactions: Back Pain, Renal Failure, Pain in Extremity, Anaemia, Joint Effusion, Deep Vein Thrombosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-07-25

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Adriamycin PFS
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Decadron
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Velcade
    Dosage: 2.6 mg, cyclic
    Start date: 2011-07-25
    End date: 2012-04-23

Aredia
    Dosage: unk
    Indication: Hypercalcaemia
    Start date: 2011-03-07
    End date: 2011-07-14

Other drugs received by patient: B12-Vitamin



Possible Decadron side effects in female

Reported by a physician from Japan on 2012-07-31

Patient: female, weighing 34.5 kg (75.9 pounds)

Reactions: White Blood Cell Count Decreased, Urinary Tract Infection, Febrile Neutropenia, Multiple Myeloma, Neutrophil Count Decreased, Hypertension

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-02
    End date: 2010-10-22

Decadron
    Dosage: 6.6mg x 2
    Start date: 2010-10-30
    End date: 2010-11-02

Decadron
    Dosage: 1.65g x 1
    Start date: 2010-10-30
    End date: 2010-11-02

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2010-11-27
    End date: 2010-12-02

Decadron
    Dosage: 6.6mg x 5
    Start date: 2010-10-10
    End date: 2010-10-13

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2010-10-30
    End date: 2010-11-19

Decadron
    Dosage: 6.6mg x 5
    Indication: Multiple Myeloma
    Start date: 2010-10-02
    End date: 2010-10-05

Other drugs received by patient: Omeprazole; Lasix; Fentanyl-100; Lasix; Orgaran; Loxonin; Neophyllin



Possible Decadron side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12

Patient: male, weighing 88.4 kg (194.6 pounds)

Reactions: Back Pain, Renal Failure, Pain in Extremity, Anaemia, Joint Effusion

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-07-25

Adriamycin PFS
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Aredia
    Dosage: unk
    Indication: Hypercalcaemia
    Start date: 2011-03-07
    End date: 2011-07-14

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Velcade
    Dosage: 2.6 mg, cyclic
    Start date: 2011-07-25
    End date: 2012-04-23

Decadron
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Other drugs received by patient: B12-Vitamin



Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-07-10

Patient: 69 year old male, weighing 63.4 kg (139.6 pounds)

Reactions: Extradural Abscess, Vomiting, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Decadron
    Dosage: 2 mg, daily
    Administration route: Oral
    Start date: 2011-10-29

Oxycodone HCL
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Oxycodone Hydrochloride
    Dosage: 5 mg, prn
    Administration route: Oral
    Indication: Pain
    Start date: 2010-11-11
    End date: 2011-05-05

Decadron
    Dosage: 0.5 mg, daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-09-26

Oxycodone Hydrochloride
    Dosage: 10 mg, prn
    Administration route: Oral
    Start date: 2011-05-06

Axitinib
    Dosage: 2 mg, bid
    Start date: 2010-12-14
    End date: 2011-07-14

Axitinib
    Dosage: 5 mg, bid
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Oxycodone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-06-16

Decadron
    Dosage: 1 mg, daily
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Other drugs received by patient: Hirudoid / 00723701 /; LAC B; Gasmotin; Olmesartan Medoxomil; Prorenal; Pursennid / 00142207 /; Norvasc; Teleminsoft; Mucosta; Amlodipine; Interferon Alfa; Mobic; Tizanidine Hydrochloride; Zometa; Veen D; Magnesium Oxide; Acetaminophen; Lansoprazole; Daikentyuto



Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-07-06

Patient: 69 year old male, weighing 63.4 kg (139.6 pounds)

Reactions: Extradural Abscess, Vomiting, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Oxycodone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-06-16

Axitinib
    Dosage: 2 mg, bid
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycodone Hydrochloride
    Dosage: 5 mg, prn
    Administration route: Oral
    Indication: Pain
    Start date: 2010-11-11
    End date: 2011-05-05

Oxycodone HCL
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Decadron
    Dosage: 1 mg, daily
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Axitinib
    Dosage: 5 mg, bid
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Decadron
    Dosage: 0.5 mg, daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-09-26

Decadron
    Dosage: 2 mg, daily
    Administration route: Oral
    Start date: 2011-10-29

Oxycodone Hydrochloride
    Dosage: 10 mg, prn
    Administration route: Oral
    Start date: 2011-05-06

Other drugs received by patient: Mucosta; Norvasc; Amlodipine; Acetaminophen; Interferon Alfa; Gasmotin; Magnesium Oxide; Lansoprazole; Hirudoid / 00723701 /; LAC B; Pursennid / 00142207 /; Mobic; Veen D; Tizanidine Hydrochloride; Zometa; Daikentyuto; Teleminsoft; Olmesartan Medoxomil; Prorenal



Possible Decadron side effects in 69 year old male

Reported by a individual with unspecified qualification from Japan on 2012-06-25

Patient: 69 year old male

Reactions: Vomiting, Extradural Abscess, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 5 mg/bid
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Acetaminophen
    Dosage: 5 mg/bid
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-07-29
    End date: 2011-08-18

Acetaminophen
    Dosage: 5 mg/bid
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-08-27
    End date: 2011-09-26

Decadron
    Dosage: 0.5 mg/daily 1 mg/daily 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-14
    End date: 2011-10-28

Decadron
    Dosage: 0.5 mg/daily 1 mg/daily 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Decadron
    Dosage: 0.5 mg/daily 1 mg/daily 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-10-13

Decadron
    Dosage: 0.5 mg/daily 1 mg/daily 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-29

Blinded Therapy
    Administration route: Oral
    Indication: Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycodone HCL
    Dosage: 5 mg/prn 10 mg/prn
    Indication: Pain
    Start date: 2011-05-06

Oxycodone HCL
    Dosage: 5 mg/prn 10 mg/prn
    Indication: Pain
    Start date: 2010-11-11
    End date: 2011-05-05

Oxycontin
    Dosage: 40 mg/bid 50 mg/bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Oxycontin
    Dosage: 40 mg/bid 50 mg/bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Other drugs received by patient: Acetaminophen; DAI-Kenchu-TO; Mobic; Lansoprazole; Hirudoid; LAC-B; MG Oxide; Prorenal; Zometa; Gasmotin; MG Oxide; Pursennid (Senna); Teleminsoft; Tizanidine Hydrochloride; Mucosta; Norvasc; Olmesartan Medoxomil



Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-06-15

Patient: 69 year old male, weighing 63.5 kg (139.6 pounds)

Reactions: Vomiting, Extradural Abscess, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Blinded Axitinib
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycodone Hydrochloride
    Dosage: 10 mg, as needed
    Administration route: Oral
    Start date: 2011-05-06

Decadron
    Dosage: 0.5 mg, 1x/day
    Administration route: Oral
    Start date: 2011-08-25
    End date: 2011-10-13

Oxycontin
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Start date: 2011-06-17

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Start date: 2011-07-29
    End date: 2011-08-18

Placebo
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Decadron
    Dosage: 1 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Start date: 2011-08-27
    End date: 2011-09-26

Blinded NO Subject Drug
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Decadron
    Dosage: unk mg, 1x/day
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Oxycodone Hydrochloride
    Dosage: 5 mg, as needed
    Administration route: Oral
    Indication: Pain
    Start date: 2010-11-11
    End date: 2011-05-05

Decadron
    Dosage: 2 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-29

Oxycontin
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Other drugs received by patient: Pursennid; Veen D; Amlodipine; LAC B; Tizanidine Hydrochloride; Teleminsoft; Acetaminophen; Mobic; Hirudoid; Olmesartan Medoxomil; DAI-Kenchu-TO; Norvasc; Magnesium Oxide; Lansoprazole; Hirudoid; Gasmotin; Mucosta; Prorenal; Zometa



Possible Decadron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05

Patient: female, weighing 61.1 kg (134.4 pounds)

Reactions: Neuropathy Peripheral, Lung Squamous Cell Carcinoma Stage Unspecified

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-10-28
    End date: 2012-03-16

Decadron
    Dosage: 10 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-10-28

Other drugs received by patient: Zolpidem Tartrate; Vitamin C / 00008001 /; Synthroid; Vitamin D



Possible Decadron side effects in female

Reported by a physician from Japan on 2012-05-18

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: Anal Fistula, Oesophageal Candidiasis, Subcutaneous Abscess, Rectal Perforation, Gastric Ulcer, Disease Progression

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Irinotecan Hydrochloride
    Start date: 2011-08-11
    End date: 2011-09-22

Irinotecan Hydrochloride
    Dosage: dosage is uncertain.
    Start date: 2011-05-19
    End date: 2011-01-01

Lobu
    Administration route: Oral
    Indication: Cancer Pain
    Start date: 2010-11-18
    End date: 2011-11-01

Decadron
    Dosage: dosage is uncertain.
    Indication: Product Used FOR Unknown Indication

Avastin
    Start date: 2010-08-05
    End date: 2011-01-06

Avastin
    Start date: 2011-03-17
    End date: 2011-04-28

TS-1
    Dosage: it is two administering weekly holiday medicine for two weeks.
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    Start date: 2011-08-11
    End date: 2011-09-21

Irinotecan Hydrochloride
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Metastatic
    Start date: 2011-04-28
    End date: 2011-04-28

Avastin
    Start date: 2011-08-11
    End date: 2011-09-22

Avastin
    Indication: Rectal Cancer Metastatic
    Start date: 2009-11-04
    End date: 2010-04-21

Other drugs received by patient: Fluorouracil; Levoleucovorin Calcium; Levoleucovorin Calcium; Vectibix; Fluorouracil; Fluorouracil; Fluorouracil



Possible Decadron side effects in female

Reported by a physician from Japan on 2012-04-25

Patient: female

Reactions: White Blood Cell Count Decreased, Renal Failure, Platelet Count Decreased, Multiple Myeloma, Oral Herpes

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-15
    End date: 2010-10-21

Decadron
    Dosage: 13.2 milligram
    Indication: Multiple Myeloma
    Start date: 2010-10-15
    End date: 2010-10-15

Other drugs received by patient: Vitamin B12; Levothyroxine Sodium; Omeprazole



Possible Decadron side effects in 63 year old female

Reported by a physician from United States on 2012-03-23

Patient: 63 year old female

Reactions: Dyspnoea

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 mg, 1 in 1 d, po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-08-03

Decadron
    Dosage: 40 mg, daily
    Indication: Multiple Myeloma
    Start date: 2011-07-29

Other drugs received by patient: Lotrel; Bystolic; Folic Acid; Dexamethasone; Metformin HCL; Hydrochloric Acid



Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-02-29

Patient: 69 year old male, weighing 63.4 kg (139.6 pounds)

Reactions: Vomiting, Extradural Abscess, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Oxycodone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-06-16

Decadron
    Dosage: 1 mg, daily
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Decadron
    Dosage: 0.5 mg, daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-09-26

Axitinib
    Dosage: 5 mg, bid
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Oxycodone HCL
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Axitinib
    Dosage: 2 mg, bid
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycodone HCL
    Dosage: 10 mg, prn
    Indication: Pain
    Start date: 2011-05-06

Decadron
    Dosage: 2 mg, daily
    Administration route: Oral
    Start date: 2011-10-29

Other drugs received by patient: Zometa; Mucosta; Daikentyuto; Teleminsoft; Lansoprazole; Acetaminophen; Prorenal; Veen D; Gasmotin; Interferon Alfa; Magnesium Oxide; LAC B; Mobic; Tizanidine HCL; Pursennid / 00142207 /; Hirudoid / 00723701 /; Olmesartan Medoxomil; Amlodipine; Norvasc



Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-02-23

Patient: 69 year old male

Reactions: Vomiting, Diplegia, Pyrexia, Extradural Abscess, Sensory Disturbance, Abdominal Distension, Enterocolitis, White Blood Cell Count Increased, Decreased Appetite

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Oxycontin
    Dosage: 40;50 mg/bid, po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Oxycontin
    Dosage: 40;50 mg/bid, po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Blinded Therapy
    Dosage: 40;50 po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Decadron
    Dosage: 0.5; 1; 2 po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-29

Decadron
    Dosage: 0.5; 1; 2 po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-10-13

Decadron
    Dosage: 0.5; 1; 2 po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Decadron
    Dosage: 0.5; 1; 2 po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-14
    End date: 2011-10-28

Oxycodone Hydrochloride
    Dosage: 10 mg/prn
    Indication: Pain
    Start date: 2011-05-06

Axitinib
    Dosage: 5 mg/bid, po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-08-27
    End date: 2011-09-26

Axitinib
    Dosage: 5 mg/bid, po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-07-29
    End date: 2011-08-18

Axitinib
    Dosage: 5 mg/bid, po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Other drugs received by patient: DAI-Kenchu-TO; Hirudoid; Acetaminophen; Mobic; Norvasc; Teleminsoft; Lansoprazole; LAC-B; Prorenal; Tizanidine HCL; Zometa; Mucosta; Olmesartan Medoxomil; Gasmotin; MG Oxide; Pursennid (Senna)



Possible Decadron side effects in 69 year old male

Reported by a individual with unspecified qualification from Japan on 2012-02-15

Patient: 69 year old male

Reactions: Extradural Abscess, Vomiting, Stomatitis, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Decadron
    Dosage: unk;po, 0.5 mg/daily, 1 mg/daily, 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-10-13

Decadron
    Dosage: unk;po, 0.5 mg/daily, 1 mg/daily, 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-14
    End date: 2011-10-28

Decadron
    Dosage: unk;po, 0.5 mg/daily, 1 mg/daily, 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-29

Decadron
    Dosage: unk;po, 0.5 mg/daily, 1 mg/daily, 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Blinded Therapy
    Dosage: unk;po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycontin
    Dosage: 40 mg/bid;po, 50 mg/bid;po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Oxycontin
    Dosage: 40 mg/bid;po, 50 mg/bid;po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Axitinib
    Dosage: 5 mg/bid;po, 5 mg/bid;po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-07-29
    End date: 2011-08-18

Axitinib
    Dosage: 5 mg/bid;po, 5 mg/bid;po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-08-27
    End date: 2011-09-26

Axitinib
    Dosage: 5 mg/bid;po, 5 mg/bid;po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Oxycodone Hydrochloride
    Dosage: po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-06

Other drugs received by patient: Hirudoid; MG Oxide; LAC-B; Mucosta; Prorenal; Gasmotin; Pursennid (Senna); DAI-Kenchu-TO; Teleminsoft; Zometa; Acetaminophen; Lansoprazole; Tizanidine HCL; Mobic; Norvasc; Olmesartan Medoxomil



Possible Decadron side effects in male

Reported by a physician from Japan on 2012-02-14

Patient: male, weighing 63.5 kg (139.6 pounds)

Reactions: Vomiting, Extradural Abscess, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Decadron
    Dosage: unk mg, 1x/day
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Start date: 2011-08-27
    End date: 2011-09-26

Blinded NO Subject Drug
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Start date: 2011-07-29
    End date: 2011-08-18

Blinded Axitinib
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Oxinorm
    Dosage: 10 mg, as needed
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-06

Decadron
    Dosage: 1 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Oxycontin
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Start date: 2011-06-17

Blinded Placebo
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Decadron
    Dosage: 2 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-29

Oxycontin
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Decadron
    Dosage: 0.5 mg, 1x/day
    Administration route: Oral
    Start date: 2011-08-25
    End date: 2011-10-13

Other drugs received by patient: Norvasc; Lansoprazole; Tizanidine HCL; Gasmotin; Mobic; DAI-Kenchu-TO; Veen D; Pursennid; Acetaminophen; Zometa; Magnesium Oxide; Hirudoid; Olmesartan Medoxomil; Hirudoid; LAC B; Prorenal; Teleminsoft; Mucosta; Amlodipine



Possible Decadron side effects in 80 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-03

Patient: 80 year old male

Reactions: Dyspnoea

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Decadron
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-30
    End date: 2011-10-01

Decadron
    Administration route: Oral
    Indication: Asthenia
    Start date: 2011-09-30
    End date: 2011-10-01

Decadron
    Administration route: Oral
    Start date: 2011-10-01
    End date: 2011-10-01

Decadron
    Administration route: Oral
    Start date: 2011-10-01
    End date: 2011-10-01

Other drugs received by patient: Gonadorelin INJ; Albuterol; Salmeterol; Moviprep; MS Contin



Possible Decadron side effects in 64 year old male

Reported by a physician from United States on 2011-11-08

Patient: 64 year old male

Reactions: Osteonecrosis of JAW

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 mg, 21 days in month, oral
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-08-01
    End date: 2010-03-01

Decadron
    Dosage: 40 mg, qw
    Indication: Multiple Myeloma
    Start date: 2008-01-01

Decadron
    Dosage: 40 mg, qw
    Indication: Multiple Myeloma
    Start date: 2004-01-01

Zometa
    Dosage: 4 mg, qmo, intravenous
    Indication: Multiple Myeloma
    Start date: 2008-05-01
    End date: 2009-08-01

Other drugs received by patient: Cytoxan



Possible Decadron side effects in 80 year old male

Reported by a consumer/non-health professional from United Kingdom on 2011-10-14

Patient: 80 year old male

Reactions: Dyspnoea, Fear, Wheezing

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Decadron

Other drugs received by patient: Decapeptyl; MST (Magnesium Salicylate); Moviprep



Possible Decadron side effects in female

Reported by a physician from Japan on 2011-10-04

Patient: female

Reactions: White Blood Cell Count Decreased, Renal Failure, Platelet Count Decreased, Multiple Myeloma, Oral Herpes

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-15
    End date: 2010-10-21

Decadron
    Dosage: 13.2 milligram
    Indication: Multiple Myeloma
    Start date: 2010-10-15
    End date: 2010-10-15

Other drugs received by patient: Levothyroxine Sodium; Methycobal; Omeprazole



Possible Decadron side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-04

Patient: 51 year old female

Reactions: Pancreatitis Acute, Chills, Hyperhidrosis, Pallor, Pancreatitis Necrotising, Glomerulonephritis, Obesity, Chest Pain, Gastrooesophageal Reflux Disease, Renal Failure Acute, Refusal of Treatment by Patient, Type 2 Diabetes Mellitus, Blood Triglycerides Decreased, Hyponatraemia, Haemodialysis, Heart Rate Decreased, Skin Neoplasm Excision, Hypertension, Sleep Apnoea Syndrome, Influenza Like Illness

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Intron A
    Dosage: iv; iv
    Indication: Malignant Melanoma Stage III
    Start date: 2011-03-28
    End date: 2011-04-01

Intron A
    Dosage: iv; iv
    Indication: Malignant Melanoma Stage III
    Start date: 2011-03-21
    End date: 2011-03-25

Decadron

Other drugs received by patient: Compazine; Hydrochlorothiazide; Aspirin; Percocet; Norvasc

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017